Quinbrook Shuffles Leadership as It Focuses on Supply Chains, Critical Minerals
The Houston-based clean-energy infrastructure specialist with roots in Australia last month named Managing Director Brian Restall as the firm's chief executive, a newly created role. He will move into the job by year-end. Restall currently is Quinbrook's regional leader for Australia.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
37 minutes ago
- Yahoo
Deutsche Bank Says PepsiCo (PEP) Needs to Win Investor Confidence
PepsiCo, Inc. (NASDAQ:PEP) is one of the . On June 27, Deutsche Bank released a note regarding PepsiCo, Inc. (NASDAQ:PEP), highlighting that the company needs to win investor confidence as its current strategy is under question due to dropping snack consumption trends in the US. PepsiCo, Inc. (NASDAQ:PEP) is set to release its Q2 2025 results on July 17. Deutsche Bank analyst Steve Powers noted that with the earnings call approaching, the company needs to show some increased sense of urgency to gain investor confidence. He added that although the bank continues to believe that the intrinsic value of PepsiCo, Inc. (NASDAQ:PEP) exceeds its current trading value, the declining consumption trends in the US have disappointed the bull case for the company. A close up of a glass of a refreshing carbonated beverage illustrating the company's different beverages. Powers noted that the upcoming earnings call will be important for the company as it should point to some meaningful conversation regarding how the future will be different from the past. While we acknowledge the potential of PEP as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio
Yahoo
38 minutes ago
- Yahoo
Merck & Co (MRK) Announces the Approval of ENFLONSIA
Merck & Co., Inc. (NYSE:MRK) is one of the 11 Best 52-Week Low Stocks to Buy Right Now. On June 26, Merck & Co., Inc. (NYSE:MRK) announced that the Advisory Committee on Immunization Practices has approved ENFLONSIA for preventing respiratory syncytial virus in infants younger than 8 months. The recommendation is provisional and is pending the final approval of the CDC Director or the Health and Human Services Secretary. Merck & Co., Inc. (NYSE:MRK) noted that ENFLONSIA is the first and only RSV preventive option administered to infants using the same dose regardless of weight, simplifying dosing logistics. Moreover, earlier this month, the FDA approved ENFLONSIA based on the strong clinical trial data from the Phase 2b/3 CLEVER and Phase 3 SMART trials. The results showed a 60.5% reduction in medically attended RSV lower respiratory infections and an 84.3% reduction in RSV-associated hospitalizations. A close-up of a person's hand holding a bottle of pharmaceuticals. Merck & Co., Inc. (NYSE:MRK) is a global healthcare company that operates through two main business segments including the Pharmaceuticals and Animal Health Segments. It is known for Keytruda and Gardasil, which are the main sources of the company's revenue. While we acknowledge the potential of MRK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
38 minutes ago
- Yahoo
The Procter & Gamble Company (PG) Is Expected to Cut 7,000 Jobs Over the Next 2 Years
The Procter & Gamble Company (NYSE:PG) is one of the . On June 5, Reuters reported that The Procter & Gamble Company (NYSE:PG) is expected to cut 7,000 jobs over the next two years. This comes as a response to the challenges from the uncertain spending environment in the United States due to the tariffs. The Procter & Gamble Company (NYSE:PG) is also expected to exit some product categories and brands, with anticipated divestitures in certain markets. The job cut of 7,000 represents around 6% of its total workforce. Management has characterized it as part of its ongoing strategy and two-year restructuring program. A happy couple viewing the products of this household and personal product company in a mass merchandiser store. The Procter & Gamble Company (NYSE:PG) is a leading global consumer company that provides branded daily life products. The company operates through five main segments which include Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine, and Family Care. While we acknowledge the potential of PG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.
